Sign In
Buy RMTI
$0.676
-0.0334 (-4.71%)
At Close: Jun 03, 2026
Rockwell Medical (RMTI) Reports Q4 Loss, Lags Revenue Estimates
06:58pm, Wednesday, 31'st Mar 2021
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -5.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical: Q4 Earnings Insights
04:29pm, Wednesday, 31'st Mar 2021
Shares of Rockwell Medical (NASDAQ:RMTI) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.18% year over year to ($0.09), which m
Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update
04:05pm, Wednesday, 31'st Mar 2021
- 2020 revenue of $62.2 million -
Rockwell Medical's Earnings: A Preview
10:06am, Tuesday, 30'th Mar 2021
On Wednesday, March 31, Rockwell Medical (NASDAQ:RMTI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:44pm, Wednesday, 24'th Mar 2021
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Rockwell Medical (RMTI) Stock We Don't?
09:06am, Wednesday, 17'th Mar 2021
Investors need to pay close attention to Rockwell Medical (RMTI) stock based on the movements in the options market lately.
WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
07:00am, Monday, 01'st Feb 2021
>82,000 patients receiving hemodialysis annually >82,000 patients receiving hemodialysis annually
Rockwell Medical (RMTI) Looks Good: Stock Adds 5.9% in Session
09:47am, Thursday, 14'th Jan 2021
Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
07:00am, Wednesday, 13'th Jan 2021
China is a sizable and growing market, with more than 600,000 patients receiving hemodialysis annually China is a sizable and growing market, with more than 600,000 patients receiving hemodialysis ann
Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference
07:00am, Tuesday, 05'th Jan 2021
WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q3 2020 Results - Earnings Call Transcript
08:49pm, Monday, 09'th Nov 2020
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q3 2020 Results - Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q2 2020 Results - Quick Version Earnings Call Transcript
06:16pm, Monday, 09'th Nov 2020
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q2 2020 Results - Quick Version Earnings Call Transcript
Recap: Rockwell Medical Q3 Earnings
05:02pm, Monday, 09'th Nov 2020
Shares of Rockwell Medical (NASDAQ:RMTI) fell 2.17% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 16.67% over the past year to ($0.10), which
Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020
08:00am, Tuesday, 27'th Oct 2020
WIXOM, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of
